VTRS
$VTRS
Viatris Inc.
Global pharmaceutical company formed from Mylan and Pfizer Upjohn merger making generic and branded drugs.
Healthcare$13.83
+0.36 (+2.67%)
Day Range$13.37 - $13.86
Prev Close$13.47
Analyst Rating
Strong Buy
12 Buy / 5 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 19
Weekly updates
Latest Report
VTRS: Value Play with Strong FCF Catalysts
Viatris ($VTRS) trades near $13 with a sub-1 P/B, a 3.7% yield, and a low forward P/E, while analysts lift targets after debt reduction and pipeline updates. The stock offers yield plus potential upside if FCF converts to sustainable earnings.
Mar 30, 2026